Physician profile
Ramesh Kumar Moolani
NPI 1437272010
$27,356.13
in general payments reported to CMS, 2019-2025
82 companies · $5,111 in 2025
The $5,111 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,160 · 2020: $1,633 · 2021: $4,319 · 2022: $3,858 · 2023: $4,971 · 2024: $5,304 · 2025: $5,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Long Term Medical Supply Or Device Loan: $2,250 · Education: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,652.15 |
| Long Term Medical Supply Or Device Loan | $2,249.91 |
| Education | $484.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,678.91 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,708.52 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $1,697.88 | 2019-2025 | Imfinzi, Lynparza |
| Janssen Biotech, INC. | $1,440.04 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Pfizer INC. | $1,233.88 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $993.78 | 2019-2025 | Opdivo, Opdualag |
| Takeda Pharmaceuticals U.S.A., INC. | $885.29 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Pharmacyclics LLC, An Abbvie Company | $752.66 | 2019-2023 | Imbruvica, Epkinly |
| Amgen INC. | $733.56 | 2020-2024 | Krystexxa |
| Celgene Corporation | $729.28 | 2019-2025 | Reblozyl, Breyanzi, Opdualag |
| Seagen INC. | $669.69 | 2019-2023 | Adcetris, Tukysa |
| Astellas Pharma US INC | $637.07 | 2020-2025 | Vyloy, Xospata, Padcev |
| Eisai INC. | $628.35 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $605.59 | 2020-2025 | |
| Sobi, INC | $557.95 | 2022-2025 |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $529.86 | 2019-2025 | Jakafi, Monjuvi |
| Daiichi Sankyo INC. | $490.40 | 2019-2025 | Enhertu, Injectafer, Vanflyta |
| Puma Biotechnology, INC. | $471.99 | 2019-2025 | |
| Abbvie INC. | $462.04 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $352.02 | 2021-2025 | Ultomiris |
| Lilly USA, LLC | $352.00 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Beigene USA, INC. | $344.39 | 2020-2025 | Brukinsa, Tevimbra |
| Regeneron Healthcare Solutions, INC. | $315.97 | 2021-2025 | Libtayo |
| Kite Pharma, INC. | $310.42 | 2020-2025 | Yescarta |
| Epizyme, INC. | $299.46 | 2020-2022 | |
| Exelixis INC. | $297.28 | 2019-2025 | Cabometyx |
| Rigel Pharmaceuticals, INC. | $287.84 | 2019-2024 | Rezlidhia, Tavalisse |
| Gilead Sciences, INC. | $284.01 | 2019-2025 | Trodelvy |
| Array Biopharma INC | $195.28 | 2019-2025 | Braftovi, Mektovi, Xalkori |
| Karyopharm Therapeutics INC. | $186.74 | 2020-2025 | Xpovio |
| Blueprint Medicines Corporation | $181.03 | 2020-2025 | Ayvakit |
| Ipsen Biopharmaceuticals, INC | $171.44 | 2021-2025 | Tazverik, Onivyde, Somatuline Depot |
| Genentech USA, INC. | $159.11 | 2019-2022 | |
| Dova Pharmaceuticals | $151.33 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.72 | 2019-2025 | Gilotrif |
| Emd Serono, INC. | $140.40 | 2019-2025 | Bavencio |
| Mirati Therapeutics, INC. | $119.07 | 2023-2024 | Krazati |
| Amneal Pharmaceuticals LLC | $116.69 | 2023-2025 | Alymsys, Avastin, Neupogen |
| Glaxosmithkline, LLC. | $115.35 | 2022-2025 | Ojjaara |
| Beone Medicines USA, INC. | $113.69 | 2025 | Brukinsa, Tevimbra |
| Servier Pharmaceuticals LLC | $105.09 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $104.38 | 2023-2025 | Monoferric, Cosela |
| Verastem, INC. | $97.31 | 2019-2020 | |
| Taiho Oncology, INC. | $86.60 | 2019-2025 | |
| Acrotech Biopharma INC. | $86.58 | 2022-2024 | Beleodaq |
| Secura Bio, INC. | $82.41 | 2019 | |
| Coherus Oncology, INC. | $71.76 | 2022-2024 | |
| Agios Pharmaceuticals, INC. | $68.10 | 2025 | Pyrukynd |
| Stemline Therapeutics INC. | $58.03 | 2024-2025 | Orserdu |
| Recordati_rare_diseases_inc. | $57.79 | 2024-2025 | Sylvant |
| Eusa Pharma (US) LLC | $57.40 | 2022 | |
| Genzyme Corporation | $51.89 | 2021-2025 | |
| Tersera Therapeutics LLC | $51.79 | 2023-2024 | Xermelo, Zoladex |
| Lexicon Pharmaceuticals, INC. | $47.50 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $46.34 | 2019 | |
| Jazz Pharmaceuticals INC. | $44.82 | 2019-2024 | |
| Myriad Genetic Laboratories, INC. | $44.09 | 2023 | Myrisk |
| Foundation Medicine, INC. | $42.98 | 2020 | |
| Heron Therapeutics, INC. | $40.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $39.45 | 2020-2021 | |
| Spectrum Pharmaceuticals INC. | $38.31 | 2023-2025 | Rolvedon |
| Pharmaessentia USA Corporation | $33.50 | 2025 | Besremi |
| Csl Behring | $33.13 | 2019 | |
| Caris Mpi, INC. | $29.72 | 2025 | Mi Cancer Seek |
| Janssen Scientific Affairs, LLC | $29.29 | 2019 | |
| Adc Therapeutics America, INC. | $29.07 | 2022 | |
| Myovant Sciences INC. | $28.63 | 2022 | |
| Deciphera Pharmaceuticals INC. | $27.26 | 2022 | |
| Tempus Ai, INC | $26.55 | 2025 | Xt Cdx |
| Genmab U.S., INC. | $24.91 | 2024 | Epkinly |
| Sun Pharmaceutical Industries INC. | $24.75 | 2020 | |
| West Therapeutics Development, LLC | $23.57 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.55 | 2019 | |
| Immunogen, INC. | $20.58 | 2024 | Elahere |
| Clovis Oncology, INC. | $19.47 | 2020 | |
| Accord Healthcare, INC. | $16.86 | 2025 | |
| Apellis Pharmaceuticals, INC. | $16.74 | 2023 | Empaveli |
| Sanofi-Aventis U.S. LLC | $16.71 | 2019 | |
| Octapharma USA, INC. | $16.47 | 2024 | Octagam Immune Globulin (Human) |
| Alnylam Pharmaceuticals INC. | $16.42 | 2024 | Amvuttra |
| Aveo Pharmaceuticals, INC. | $16.08 | 2022 | |
| Sirtex Medical INC | $15.27 | 2020 |
Drugs and devices associated with these payments
Kisqali $2,266Keytruda $1,010Imbruvica $804Lynparza $545Lenvima $444Darzalex $396Doptelet $383Opdivo $348Reblozyl $324Tecvayli $306Welireg $300Jakafi $272Ibrance $261Nubeqa $256Ultomiris $255Libtayo $227Enhertu $224Tukysa $214Erleada $213Imfinzi $208Adcetris $207Scemblix $205Brukinsa $201Talvey $200Stivarga $185Vitrakvi $185Rybrevant $174Cabometyx $169Opdualag $168Xtandi $166Fabhalta $166Verzenio $157Padcev $148Mektovi $143Braftovi $143Ninlaro $141Piqray $140Vyloy $139Fruzaqla $138Elrexfio $137Epkinly $133Jaypirca $131Alunbrig $122Talzenna $121Krazati $119Krystexxa $116Elahere $116Rezlidhia $115Tavalisse $115Orgovyx $114Breyanzi $108Inlyta $108Xpovio $105Yescarta $101Paxlovid $100Comirnaty $100Lorbrena $99.21Xalkori $99.21Xospata $96.38Trodelvy $92.27Keytruda Qlex $92.06Monjuvi $90.29Tevimbra $89.07Injectafer $85.04Tazverik $83.60Nerlynx $83.48Ayvakit $81.27Venclexta $76.10Pluvicto $70.45Onivyde $68.64Pyrukynd $68.10Tibsovo $65.57Monoferric $65.42Beleodaq $63.62Lutathera $58.63Orserdu $58.03Sylvant $57.79Carvykti $55.97Ojjaara $55.79Alymsys $51.67Bavencio $45.57Promacta $45.15Somatuline Depot $44.90Myrisk $44.09Idhifa $42.48Vonjo $42.02Neupogen $40.46Neulasta $40.46Avastin $40.46Cosela $38.96Rolvedon $38.31Bosulif $35.27Besponsa $35.27Inqovi $34.42Lonsurf $34.42Retevmo $34.24Besremi $33.50Mi Cancer Seek $29.72Pomalyst $29.27Vanflyta $28.62
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Moolani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.